scispace - formally typeset
M

Marc A. Pfeffer

Researcher at Brigham and Women's Hospital

Publications -  815
Citations -  143710

Marc A. Pfeffer is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 166, co-authored 765 publications receiving 133043 citations. Previous affiliations of Marc A. Pfeffer include Partners HealthCare & University of Miami.

Papers
More filters
Journal Article

Characterization of myocardial infarcts in the rat.

J Spadaro, +4 more
- 01 Apr 1980 - 
TL;DR: In 42 male Sprague-Dawley rats, the distribution of coronary arteries, the geometry of myocardial infarcts (MIs) and the involvement of the left ventricular papillary and trabecular muscles, after left coronary occlusion, were investigated.
Journal ArticleDOI

Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.

Marc A. Pfeffer, +3 more
- 01 Jun 1977 - 
TL;DR: Administration of the beta-adrenergic receptor blocking agents, propranolol or timolol, from conception through the developmental stage of SHR hypertension, failed to alter either the progressive rise in arterial pressure or the development of hypertensive vascular disease and left ventricular hypertrophy.
Journal ArticleDOI

Augmentation index and central aortic stiffness in middle-aged to elderly individuals

Mitul Vyas, +7 more
- 01 Jun 2007 - 
TL;DR: Increased AI is not a reliable surrogate for increased aortic stiffness and may be attributable to impedance matching and reduced wave reflection at the interface between the aorta and the muscular arteries.
Journal ArticleDOI

Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).

Sheila M. Hegde, +10 more
- 12 Sep 2017 - 
TL;DR: In patients with HF with preserved ejection fraction, both poor and intermediate self-reported PA were associated with higher risk of HF hospitalization and mortality.
Journal ArticleDOI

Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.

Hicham Skali, +13 more
- 20 Dec 2011 - 
TL;DR: In this paper, a multivariate logistic regression model was used to identify baseline predictors of stroke in 4038 patients with diabetes mellitus, chronic kidney disease, and anemia randomized to receive darbepoetin alfa or placebo.